Treatment

CAL101 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
This study is testing a new medicine called CAL101 for Idiopathic Pulmonary Fibrosis (IPF). It aims to see if CAL101 can help stop lungs from getting worse in adults with IPF, compared to a dummy treatment.
For: Idiopathic Pulmonary Fibrosis
United States · Denmark · France